These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3051529)

  • 1. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results.
    Gent M; Blakely JA; Easton JD; Ellis DJ; Hachinski VC; Harbison JW; Panak E; Roberts RS; Sicurella J; Turpie AG
    Stroke; 1988 Oct; 19(10):1203-10. PubMed ID: 3051529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.
    Gent M; Blakely JA; Easton JD; Ellis DJ; Hachinski VC; Harbison JW; Panak E; Roberts RS; Sicurella J; Turpie AG
    Lancet; 1989 Jun; 1(8649):1215-20. PubMed ID: 2566778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian American ticlopidine study (cats) in thromboembolic stroke.
    Gent M; Ellis D
    Agents Actions Suppl; 1984; 15():283-96. PubMed ID: 6385653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "trials" of a long-term clinical trial: the Ticlopidine Aspirin Stroke Study and the Canadian-American Ticlopidine Study.
    Goyan JE
    Control Clin Trials; 1989 Dec; 10(4 Suppl):236S-244S. PubMed ID: 2691211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy in the prevention of stroke.
    Easton JD
    Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy in the treatment of cerebrovascular disease.
    Couch JR
    Clin Cardiol; 1993 Oct; 16(10):703-10. PubMed ID: 8222382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticlopidine: a new antiplatelet agent for cerebrovascular disease.
    Robert S; Miller AJ; Fagan SC
    Pharmacotherapy; 1991; 11(4):317-22; discussion 322-5. PubMed ID: 1923914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications.
    Arcan JC; Blanchard J; Boissel JP; Destors JM; Panak E
    Angiology; 1988 Sep; 39(9):802-11. PubMed ID: 3048155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.
    Bellavance A
    Stroke; 1993 Oct; 24(10):1452-7. PubMed ID: 8378945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the Ticlopidine Aspirin Stroke Study.
    Harbison JW
    Stroke; 1992 Dec; 23(12):1723-7. PubMed ID: 1448821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy in the prevention of ischaemic stroke.
    Verry M; Panak E; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ticlopidine in the prevention of thromboembolic events in patients with VVI pacemakers.
    Fazio S; Santomauro M; Cittadini A; Ferraro S; Lucariello A; Maddalena G; Sacca L
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 1):168-73. PubMed ID: 1706501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study.
    Janzon L; Bergqvist D; Boberg J; Boberg M; Eriksson I; Lindgärde F; Persson G; Almgren B; Fagher B; Kjellström T
    J Intern Med; 1990 May; 227(5):301-8. PubMed ID: 2187948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and baseline results of the monosialoganglioside early stroke trial. The EST Study Group.
    Rocca WA; Dorsey FC; Grigoletto F; Gent M; Roberts RS; Walker MD; Easton JD; Bruno R; Carolei A; Sancesario G
    Stroke; 1992 Apr; 23(4):519-26. PubMed ID: 1561683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders.
    McTavish D; Faulds D; Goa KL
    Drugs; 1990 Aug; 40(2):238-59. PubMed ID: 2226215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
    Balsano F; Coccheri S; Libretti A; Nenci GG; Catalano M; Fortunato G; Grasselli S; Violi F; Hellemans H; Vanhove P
    J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.
    Hass WK; Easton JD; Adams HP; Pryse-Phillips W; Molony BA; Anderson S; Kamm B
    N Engl J Med; 1989 Aug; 321(8):501-7. PubMed ID: 2761587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new technique in the treatment of thromboembolic stroke Preliminary Report.
    Leon-Sotomayor L
    Angiology; 1980 Nov; 31(11):729-43. PubMed ID: 6161569
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of EMATAP: a double-blind placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease.
    Blanchard J; Carreras LO; Kindermans M
    Nouv Rev Fr Hematol (1978); 1994; 35(6):523-8. PubMed ID: 8152898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents.
    Apollonio A; Castignani P; Magrini L; Angeletti R
    J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.